These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 7810170
21. Biotransformation of perchloroethene: dose-dependent excretion of trichloroacetic acid, dichloroacetic acid, and N-acetyl-S-(trichlorovinyl)-L-cysteine in rats and humans after inhalation. Völkel W, Friedewald M, Lederer E, Pähler A, Parker J, Dekant W. Toxicol Appl Pharmacol; 1998 Nov; 153(1):20-7. PubMed ID: 9875296 [Abstract] [Full Text] [Related]
22. Bioactivation and toxicity in vitro of HCFC-123 and HCFC-141b: role of cytochrome P450. Zanovello A, Ferrara R, Tolando R, Bortolato S, White IN, Manno M. Toxicol Lett; 2001 Oct 15; 124(1-3):139-52. PubMed ID: 11684366 [Abstract] [Full Text] [Related]
23. Metabolism of the hydrochlorofluorocarbon 1,2-dichloro-1,1-difluoroethane. Harris JW, Anders MW. Chem Res Toxicol; 1991 Oct 15; 4(2):180-6. PubMed ID: 1782346 [Abstract] [Full Text] [Related]
24. Rat to human extrapolation of HCFC-123 kinetics deduced from halothane kinetics: a corollary approach to physiologically based pharmacokinetic modeling. Williams RJ, Vinegar A, McDougal JN, Jarabek AM, Fisher JW. Fundam Appl Toxicol; 1996 Mar 15; 30(1):55-66. PubMed ID: 8812223 [Abstract] [Full Text] [Related]
25. Biotransformation of 2,3,3,3-tetrafluoropropene (HFO-1234yf) in rabbits. Schuster P, Bertermann R, Rusch GM, Dekant W. Toxicol Appl Pharmacol; 2010 May 01; 244(3):247-53. PubMed ID: 20045018 [Abstract] [Full Text] [Related]
26. Conditions influencing the rat liver microsomal metabolism of 2,2,-dichloro-1,1,1-trifluoroethane (HCFC-123). Godin CS, Drerup JM, Vinegar A. Drug Metab Dispos; 1993 May 01; 21(3):551-3. PubMed ID: 8100516 [No Abstract] [Full Text] [Related]
27. Tissue acylation by the chlorofluorocarbon substitute 2,2-dichloro-1,1,1-trifluoroethane. Harris JW, Pohl LR, Martin JL, Anders MW. Proc Natl Acad Sci U S A; 1991 Feb 15; 88(4):1407-10. PubMed ID: 1996342 [Abstract] [Full Text] [Related]
28. Reductive activation of HCFC-123 by methaemalbumin. Zanovello A, Ferrara R, Manno M. Toxicol Lett; 2003 Sep 15; 144(1):127-36. PubMed ID: 12919730 [Abstract] [Full Text] [Related]
29. Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons. Hoet P, Graf ML, Bourdi M, Pohl LR, Duray PH, Chen W, Peter RM, Nelson SD, Verlinden N, Lison D. Lancet; 1997 Aug 23; 350(9077):556-9. PubMed ID: 9284778 [Abstract] [Full Text] [Related]
30. Bioactivation and cytotoxicity of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) in isolated rat hepatocytes. Ferrara R, Zanovello A, Bortolato S, White IN, Manno M. Pharmacol Toxicol; 2001 Apr 23; 88(4):192-7. PubMed ID: 11322177 [Abstract] [Full Text] [Related]
31. Hepatotoxicity in guinea pigs following acute inhalation exposure to 1,1-dichloro-2,2,2-trifluoroethane. Marit GB, Dodd DE, George ME, Vinegar A. Toxicol Pathol; 1994 Apr 23; 22(4):404-14. PubMed ID: 7817129 [Abstract] [Full Text] [Related]
32. Biotransformation of trans-1-chloro-3,3,3-trifluoropropene (trans-HCFO-1233zd). Schmidt T, Bertermann R, Rusch GM, Tveit A, Dekant W. Toxicol Appl Pharmacol; 2013 May 01; 268(3):343-51. PubMed ID: 23428393 [Abstract] [Full Text] [Related]
33. 1,1,1-Trifluoro-2,2-dichloroethane (HCFC-123) and 1,1,1-trifluoro-2-bromo-2-chloroethane (halothane) cause similar biochemical effects in rats exposed by inhalation for five days. Keller DA, Lieder PH, Brock WJ, Cook JC. Drug Chem Toxicol; 1998 Nov 01; 21(4):405-15. PubMed ID: 9839153 [Abstract] [Full Text] [Related]
34. N-acetyl-S-(1,2,2-trichlorovinyl)-L-cysteine and 2,2,2-trichloroethanol: two novel metabolites of tetrachloroethene in humans after occupational exposure. Birner G, Rutkowska A, Dekant W. Drug Metab Dispos; 1996 Jan 01; 24(1):41-8. PubMed ID: 8825189 [Abstract] [Full Text] [Related]
35. Effects of HCFC-123 exposure to maternal and infant rhesus monkeys on hepatic biochemistry, lactational parameters and postnatal growth. Cappon GD, Keller DA, Brock WJ, Slauter RW, Hurtt ME. Drug Chem Toxicol; 2002 Nov 01; 25(4):481-96. PubMed ID: 12378954 [Abstract] [Full Text] [Related]
36. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K. Arzneimittelforschung; 1998 Oct 01; 48(10):995-1006. PubMed ID: 9825117 [Abstract] [Full Text] [Related]
37. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats. Duchêne P, Giudicelli MD, Neau B, Gronfier A, Firmin Y, Villax P, Saivin S, Houin G. Arzneimittelforschung; 1998 Apr 01; 48(4):371-8. PubMed ID: 9608879 [Abstract] [Full Text] [Related]
38. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene. Nauhaus SK, Fennell TR, Asgharian B, Bond JA, Sumner SC. Chem Res Toxicol; 1996 Jun 01; 9(4):764-73. PubMed ID: 8831821 [Abstract] [Full Text] [Related]
39. Effect of beta-naphthoflavone and phenobarbital on the nephrotoxicity of chlorotrifluoroethylene and 1,1-dichloro-2,2-difluoroethylene in the rat. Morel G, Ban M, Bonnet P, Zissu D, Brondeau MT. J Appl Toxicol; 2005 Jun 01; 25(2):153-65. PubMed ID: 15744758 [Abstract] [Full Text] [Related]
40. Metabolism in vivo and in vitro of the refrigerant substitute 1,1,1,2-tetrafluoro-2-chloroethane. Olson MJ, Johnson JT, O'Gara JF, Surbrook SE. Drug Metab Dispos; 1991 Jun 01; 19(5):1004-11. PubMed ID: 1686224 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]